Fast Facts for Board Review

Medications in Dermatology, Part 2: Immunosuppressives

Author and Disclosure Information

As part of our commitment to resident education, Cutis is excited to offer this monthly section with board-relevant, easy-to-review material. Each month this section will focus on the key facts of commonly tested topics. It will be a resource for review while on the go, for group study, or for last-minute preparation. This section is not meant to be comprehensive but rather a supplement to other study materials.

This fact sheet tabulates important data points about an array of immunomodulatory pharmacologic agents; some of them may be used in pregnancy.

To view this month's Fast Facts for Board Review, click here.

To view the answers to the practice questions, click here.


 

Recommended Reading

Cosmetic Corner: Dermatologists Weigh in on OTC Antifungals
MDedge Dermatology
FDA panel unanimously backs cobas HPV test as primary screening tool
MDedge Dermatology
U.S. tracking of HPV in cervical precancers confirms half due to 16/18
MDedge Dermatology
VIDEO: Try ‘restaurant menu’ approach to laser treatment of scars
MDedge Dermatology
‘Culture of Safety’ best defense against sharps injury
MDedge Dermatology
FDA panel unanimously supports tedizolid phosphate for severe skin infections
MDedge Dermatology
FDA panel endorses antibacterial dalbavancin
MDedge Dermatology
Primary Cutaneous Candida tropicalis Infection in a Patient With B-Cell Lymphoma
MDedge Dermatology
Recurrent Stevens-Johnson Syndrome Secondary to Mycoplasma pneumoniae Infection
MDedge Dermatology
CDC: Vaccines prevent millions of illnesses, but measles makes a return
MDedge Dermatology

Related Articles

  • Fast Facts for Board Review

    Lasers for Tattoo Removal

    As part of our commitment to resident education, Cutis is excited to offer this monthly section with board-relevant, easy-to-review...

  • Fast Facts for Board Review

    Closure Materials

    As part of our commitment to resident education, Cutis is excited to offer this monthly section with board-relevant, easy-to-review...